Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 4, 2011, Pages 1027-1035

  Drago, L ^a,b   Mattina, R ^c   Legnani, D ^b   Romano C L ^a   Vianello, E ^c   Ricci, C ^d   De Vecchi, E ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Cephalosporins; Fluoroquinolones; Haemophilus influenzae; Pseudomonas aeruginosa; Streptococcus pneumoniae; lactams

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; EPITHELIUM; HAEMOPHILUS INFLUENZAE; HUMAN; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS ALCALIGENES; STEADY STATE; STREPTOCOCCUS PNEUMONIAE; TREATMENT RESPONSE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; EPITHELIAL LINING FLUID; IN VITRO STUDY; PSEUDOMONAS AERUGINOSA;

EID: 84856569335     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400420     Document Type: Article

References (38)

1. Puhan MA, Vollenweider D, Latshang T, Steurer J, Steurer-Stey C. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review. Respir Res 2007; 8:30.
2. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:465-71. (Pubitemid 34879333)
3. Martinez-Solano L, Macia MD, Oliver A, Martinez JL. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 2008; 47:1526-33.
4. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22. (Pubitemid 29289651)
5. Dunne WM. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002; 15:155-66.
6. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292:107-13. (Pubitemid 34842181)
7. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005; 13:34-40. (Pubitemid 40082395)
8. Aslam S. Effect of antibacterials on biofilms. Am J Infect Control 2008; 36:S175e9-11.
9. Prince AS. Biofilms, antimicrobial resistance, and airway infection. N Engl J Med 2002; 347:1110-1.
10. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000; 44:1818-24. (Pubitemid 30422930)
11. Dales L, Ferris W, Vandemheen K, Aaron SD. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis 2009; 28:1275-79.
12. Kaji C, Watanabe K, Apicella MA, Watanabe H. Antimicrobial effects of fluoroquinolones for the eradication of non-typeable Haemophilus influenzae isolates within biofilms. Tohoku J Exp Med 2008; 214:121-28. (Pubitemid 351513544)
13. Maestre JR, Mateo M, Méndez ML, Aguilar L, Gimenez MJ, Alou L, Corone P, Granizo JJ, Prieto J. In vitro interference of beta-lactams with biofilm development by prevalent community respiratory tract isolates. Int J Antimicrob Agents 2010; 35:274-77.
14. Minardi D, Montanari MP, Tili E, Cochetti I, Mingoia M, Varaldo PE, Muzzonigro G. Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents. J Chemother 2008; 20:195-201. (Pubitemid 351797059)
15. Perez-Giraldo C, Gonzalez-Velasco C, Sanchez-Silos RM, Hurtado C, Blanco MT, Gomez-Garcia AC. Moxifloxacin and biofilm production by coagulase-negative staphylococci. Chemotherapy 2004; 50:101-4. (Pubitemid 38813021)
16. Rodriguez-Martinez JM, Ballesta S, Pascual A. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavualnic acid and cotrimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 2007; 30:366-68. (Pubitemid 47364777)
17. Roveta S, Schito AM, Marchese A, Schito G. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents 2007; 30:415-21. (Pubitemid 47498968)
18. Christensen GD, Simpson AW, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical device. J Clin Microbiol 1985; 22:996-1006. (Pubitemid 16222727)
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. M100-S15, CLSI Wayne 2005.
20. Gotfried MH, Danziger LH, Rodvold KA. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 2001; 119:1114-22. (Pubitemid 32679439)
21. Capitano B, Mattoes HM, Shore E, O'Brien A, Braman S, Sutherland C, Nicolau DP. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 2004; 125:965-73. (Pubitemid 38367287)
22. Fraschini F, Scaglione F, Falchi M, Dugnani S, Mezzetti M, Cicchetti F, Alfano G, Pintucci GP. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man. J Chemother 1990; 2:171-77. (Pubitemid 20314460)
23. Arcidiacono MM, Demartini G, Dugnani S, Scaglione F. Legame sieroproteico e diffusione extravasale del cefodizime e del ceftriaxone in bronchitici cronici. Geriatria 1996; 8:455-62. (Pubitemid 27528778)
24. Hsu JC, Nelson B. Multiple Comparisons in the General Linear Model. J Comp Graph Stat 1998; 7:23-41.
25. SAS Institute Inc. SAS 9.1.3 Help and Documentation, Cary, NC: SAS Institute Inc., 2000-2004.
26. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93. (Pubitemid 34303762)
27. Albertson TE, Louie S, Chan AL. The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. J Am Geriatr Soc 2010; 58:570-79.
28. Yassien M, Khardori N. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones. Diagn Microbiol Infect Dis 2001; 40:79-89. (Pubitemid 32735543)
29. Di Bonaventura G, Spedicato I, D'Antonio D, Robuffo I, Piccolomini R. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 2004; 48:151-60. (Pubitemid 38040191)
30. Wang D, Wang Y, Liu YN. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae. Chin Med J 2009; 122:1305-10.
31. Butorac-Petanjek B, Parnham MJ, Popovic-Grle S. Antibiotic therapy for exacertbations of chronic obstructive pulmonary disease (COPD). J Chemother 2010; 22:291-97.
32. Iyer Parameswaran G, Murphy TF. Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient. Drugs Aging 2009; 26:985-95.
33. Li XJ, Li Q, Si LY, Yuan QY. Bacteriological differences between patients with acute exacerbations of COPD and community acquired pneumonia. Respir Care 2011; Epub.
34. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359:2355-65.
35. Eng RHK, Padberg FT, Smith SM, Tan EN, Cherubin CE. Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 1991; 35:1824-28.
36. Gilbert P, Brown MR. Biofilms and β-lactams activity. J Antimicrob Chemother 1998; 41:571-72.
37. El-Feky MA, El-Rehewy MS, Hassan MA, Abolella HA, Abd El-Baky RM, Gad GF. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol 2009; 58:261-67.
38. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol 2010; 10:140.